Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aging01:26

Aging

185
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
185
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

2.5K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
2.5K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

333
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
333
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

669
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

1.6K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.6K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

62
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
62

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Defining the Intestinal eCBome and Oxylipin Signaling Systems in a TDP-43 Mouse Model of Frontotemporal Dementia.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

Assessment of the therapeutic effect of IGS2.7, a CK1δ protein kinase inhibitor, in combination with riluzole for the treatment of ALS-associated TDP-43 proteinopathy.

Neuropharmacology·2025
Same author

Relevance of a peripheral site of action outside the brain-blood barrier for the beneficial effects of CB<sub>2</sub> receptor activation in experimental ALS in male mice.

Cell communication and signaling : CCS·2025
Same author

Preclinical evaluation of cannabidiolic acid as a neuroprotective agent in TDP-43 transgenic mice, an experimental model of amyotrophic lateral sclerosis.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2025
Same author

Neurodegenerative Diseases: Pathogenesis and Preclinical Models for Translational Drug Discovery.

Toxicologic pathology·2025
Same author

Development of Novel Neuroprotective Agents Targeting GPCR Using in Vitro Assays.

Methods in molecular biology (Clifton, N.J.)·2025

Related Experiment Video

Updated: Sep 14, 2025

Administration of &#916;9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

206

Ageing, Neurodegeneration and the Endocannabinoid System.

Javier Fernández-Ruiz1,2,3, Onintza Sagredo4,5,6, María Gómez-Ruiz4,5,6,7

  • 1Instituto Universitario de Investigación en Neuroquímica, Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Universidad Complutense, Madrid, Spain. jjfr@med.ucm.es.

Current Topics in Behavioral Neurosciences
|July 24, 2025
PubMed
Summary

The endocannabinoid system (ECS) shows altered activity in the aging brain, impacting functions like memory. Targeting the ECS may offer neuroprotective strategies against age-related cognitive decline and neurodegenerative diseases.

Keywords:
CannabinoidsChronic neurodegenerative disordersEndocannabinoidsNeurodegenerationNeuroprotectionNeurorepairPathological brain ageingPhysiological brain ageing

More Related Videos

Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology
14:57

Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology

Published on: March 23, 2011

94.4K
Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans
14:25

Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans

Published on: September 21, 2019

7.4K

Related Experiment Videos

Last Updated: Sep 14, 2025

Administration of &#916;9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

206
Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology
14:57

Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology

Published on: March 23, 2011

94.4K
Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans
14:25

Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans

Published on: September 21, 2019

7.4K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Gerontology

Background:

  • The endocannabinoid system (ECS) plays crucial neuromodulatory roles throughout life, including in the central nervous system (CNS).
  • While ECS functions are well-studied in development and adulthood, its role in senescence and aging brains remains less explored.
  • Altered ECS activity in aged brains contributes to cognitive and motor impairments, with these changes intensifying in neurodegenerative conditions.

Purpose of the Study:

  • To review subtle alterations in the ECS of the aging brain without pathology.
  • To demonstrate how these changes mirror extreme alterations seen in pathological brain aging.
  • To explore neuroprotective therapies targeting the ECS for neurodegenerative diseases.

Main Methods:

  • Literature review synthesizing existing research on the ECS in aging and neurodegeneration.
  • Analysis of studies investigating cannabinoid receptor (CB1, CB2) expression and signaling pathways.
  • Examination of endocannabinoid-inactivating enzymes (FAAH, MAGL) in aging and disease contexts.

Main Results:

  • Aging is associated with altered ECS activity, including CB1 receptor downregulation and increased endocannabinoid-inactivating enzymes.
  • These alterations can exacerbate age-related cognitive and motor deficits.
  • Conversely, elevated endocannabinoids and CB2 receptor upregulation may represent protective adaptations.

Conclusions:

  • The ECS undergoes significant changes during brain aging, both in normal senescence and in neurodegenerative diseases.
  • Pharmacological modulation of ECS targets offers a promising therapeutic avenue for combating age-related neurodegeneration.
  • Developing effective neuroprotective treatments is critical given increasing global lifespans and the incidence of age-related disorders.